bumetanide has been researched along with Nephrosis in 1 studies
Nephrosis: Pathological processes of the KIDNEY without inflammatory or neoplastic components. Nephrosis may be a primary disorder or secondary complication of other diseases. It is characterized by the NEPHROTIC SYNDROME indicating the presence of PROTEINURIA and HYPOALBUMINEMIA with accompanying EDEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A pharmacokinetic study was undertaken to determine the bioavailability of bumetanide in grossly oedematous patients." | 9.06 | Bioavailability of bumetanide in grossly oedematous patients. ( Bailie, GR; Grennan, A; Waldek, S, 1987) |
| "A pharmacokinetic study was undertaken to determine the bioavailability of bumetanide in grossly oedematous patients." | 5.06 | Bioavailability of bumetanide in grossly oedematous patients. ( Bailie, GR; Grennan, A; Waldek, S, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailie, GR | 1 |
| Grennan, A | 1 |
| Waldek, S | 1 |
1 trial available for bumetanide and Nephrosis
| Article | Year |
|---|---|
Bioavailability of bumetanide in grossly oedematous patients.
Topics: Aged; Biological Availability; Bumetanide; Diuretics; Edema; Female; Half-Life; Humans; Male; Middle | 1987 |